SCA
CL icon

Spearhead Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Spearhead Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$342K Buy
4,867
+459
+10% +$36K 0.37% 78
2022
Q2 		$353K Buy
+4,408
New +$345K 0.05% 105

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spearhead Capital Advisors's CL Position: Q3 2022 in Review

Spearhead Capital Advisors increased its Colgate-Palmolive (CL) stake by 10% in Q3 2022, buying an estimated $36K and bringing the position to 4,867 shares worth $342K. The position accounts for 0.37% of the portfolio, ranked #78.

Spearhead Capital Advisors first reported a position in CL in Q2 2022 and has held it in 2 quarters since. The position peaked at $353K in Q2 2022. 1,615 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • Spearhead Capital Advisors held 4,867 shares of Colgate-Palmolive worth $342K as of Q3 2022.
  • Spearhead Capital Advisors bought 459 Colgate-Palmolive shares in Q3 2022, an estimated $36K.
  • Colgate-Palmolive made up 0.37% of Spearhead Capital Advisors's portfolio in Q3 2022, its #78 holding.
  • Spearhead Capital Advisors first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 2 quarters since.
  • Spearhead Capital Advisors's Colgate-Palmolive position peaked at $353K in Q2 2022.
  • 1,615 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.